Spinal Dissemination of Intracranial Glioblastoma in Bevacizumab Era: a Potential Bevacizumab-induced Mechanism
Gentian Kaloshi(Mother Teresa Hospital), Mentor Petrela(University of Medicine Tirana), Ermir Roçi(Mother Teresa Hospital), Arsen Seferi(University of Tirana), Arben Roji(Mother Teresa Hospital), Bujar Cakani, Teona Bushati(University of Tirana)
Cited by 7
Related Papers
Platinum-based Chemotherapy in Recurrent High-grade Glioma Patients: Retrospective Study
|Medical Archives|2014|22
Case Study of a Spinal Epidural Capillary Hemangioma: A 4-Year Postoperative Follow-Up
|Global Spine Journal|2013|18
Bevacizumab alone at 5 mg/kg in an every-3-week schedule for patients with recurrent glioblastomas: a single center experience.
|PubMed|2014|13
Bevacizumab Alone at 5 mg/kg in an Every-3-Week Schedule for Patients with Recurrent Glioblastomas: A Single Center Experience
|Tumori Journal|2013|13
Superficial temporal artery pseudoaneurysm presenting as a growing, pulsatile, and tender mass
|Surgical Neurology International|2016|11